Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Tirzepatide in Acute Ischemic Stroke Undergoing Endovascular Thrombectomy
NCT07734792Phase 3Not yet recruiting
- Start
- Sep 2026
- Primary completion
- May 2028
- Countries
- 1
01
Overview
A Phase 3 trial of tirzepatide in ischemic stroke. Planned start Sep 2026; status: not yet recruiting.
02
Drugs
03
Conditions
ischemic stroke
Beyond the preview
Go deeper on NCT07734792.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07734792.